SEC Filing Summary: Lion Biotechnologies, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Lion Biotechnologies, Inc. on September 8, 2014. The filing reports on corporate governance events, specifically the scheduling of the company's 2014 Annual Meeting of Stockholders. Note: The request metadata references "IOVANCE BIOTHERAPEUTICS, INC.", but the filing text explicitly identifies the registrant as Lion Biotechnologies, Inc.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to Item 8.01 (Other Events) and contains no financial statements or performance data.
Material Changes
No material financial changes versus prior periods are reported in this document. The filing solely announces the logistics for the upcoming annual meeting.
Guidance, Outlook, and Management Commentary
- Annual Meeting Schedule: The 2014 Annual Meeting is scheduled for Monday, November 3, 2014, at 9:00 a.m. Pacific Standard Time.
- Location: 21900 Burbank Boulevard, 3rd Floor, Woodland Hills, California 91367.
- Record Date: Stockholders of record as of the close of business on September 8, 2014, are entitled to vote.
- Proposal Deadlines: Stockholder proposals for inclusion in the proxy statement and nominations for the Board must be received by the Corporate Secretary no later than the close of business on Friday, September 19, 2014.
Key Facts for Investor Verification
- Verify the correct registrant name (Lion Biotechnologies, Inc.) against the metadata provided (IOVANCE BIOTHERAPEUTICS, INC.).
- Confirm the record date of September 8, 2014, to determine voting eligibility.
- Note the strict deadline of September 19, 2014, for submitting stockholder proposals or board nominations.
- Check subsequent filings for the actual results of the November 3, 2014, meeting.